Kawashima I, Tada N, Ikegami S, Nakamura S, Ueda R, Tai T
Department of Oncology, Tokyo Metropolitan Institute of Medical Science, Japan.
Int J Cancer. 1988 Feb 15;41(2):267-74. doi: 10.1002/ijc.2910410218.
Six monoclonal antibodies (MAbs) (4 IgG3 and 2 IgM) were produced by hybridomas obtained from A/J mice immunized with EL4(C57BL/6 derived-T lymphoma). They were found to react with antigens expressed on both mouse and human T-lymphomas but not on B lymphomas or normal cells. All of these antibodies reacted with the disialoganglioside GD2, GalNAc beta I----4(NeuAc alpha 2----8NeuAc alpha 2----3)Gal beta I----4Glc-Cer, by 3 different assay systems including the immune adherence inhibition test, enzyme-linked immunosorbent assay, and enzyme immunostaining on thin-layer chromatography. The binding specificities of these MAbs to disialogangliosides differed. Four MAbs (AI-201, AI-287, AI-410, and AI-425) showed restricted specificities, detecting only GD2, whereas the other 2 (AI-245 and AI-267) had a broader specificity, recognizing GD2, GD3, and GDlb. No evidence was obtained for the presence of the antigenic epitope in glycoproteins of mouse and human tumor cells. The ganglioside content of EL4 was low in comparison with that of M14 (a human melanoma cell line).
用EL4(C57BL/6来源的T淋巴瘤)免疫A/J小鼠获得的杂交瘤产生了6种单克隆抗体(MAb)(4种IgG3和2种IgM)。发现它们与小鼠和人T淋巴瘤上表达的抗原发生反应,但不与B淋巴瘤或正常细胞上的抗原反应。通过免疫黏附抑制试验、酶联免疫吸附试验和薄层色谱上的酶免疫染色这3种不同的检测系统,所有这些抗体都与双唾液酸神经节苷脂GD2(GalNAcβ1----4(NeuAcα2----8NeuAcα2----3)Galβ1----4Glc-Cer)发生反应。这些单克隆抗体与双唾液酸神经节苷脂的结合特异性有所不同。4种单克隆抗体(AI-201、AI-287、AI-410和AI-425)表现出受限的特异性,仅检测到GD2,而另外2种(AI-245和AI-267)具有更广泛的特异性,可识别GD2、GD3和GDlb。未获得在小鼠和人肿瘤细胞糖蛋白中存在抗原表位的证据。与M14(一种人黑色素瘤细胞系)相比,EL4的神经节苷脂含量较低。